Empagliflozin benefits heart failure patients with reduced and preserved ejection fraction
A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction. The late breaking study is presented in a ...
Aug 27, 2021
0
2